ABT250117P101000
- 0.00
- 0.000.00%
Abbott Laboratories Newsroom
Argus Research Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $150
Redburn Atlantic Adjusts Abbott Laboratories Price Target to $130 From $120
Abbott Labs Is Maintained at Overweight by Barclays
Abbott Laboratories Analyst Ratings
Barclays Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $158
Daiwa Adjusts Price Target on Abbott Laboratories to $133 From $125, Maintains Outperform Rating
Mizuho Securities Maintains Abbott Laboratories(ABT.US) With Hold Rating
Jefferies Financial raised the Target Price of Abbott Laboratories to $135.
RBC Capital Reiterates Outperform on Abbott Laboratories, Maintains $135 Price Target
Jefferies Adjusts Abbott Laboratories Price Target to $135 From $125, Maintains Hold Rating
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $136
BofA Securities Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
Abbott Labs Is Maintained at Buy by Stifel
Wells Fargo Maintains Overweight on Abbott Laboratories, Raises Price Target to $136
Abbott Laboratories Analyst Ratings
Abbott Labs Is Maintained at Buy by UBS
Goldman Sachs Raises Abbott Laboratories' Price Target to $138 From $132
A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $117 to $148
Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Arrowhead Pharmaceuticals (ARWR)
Abbott Laboratories: Strong Performance and Promising Outlook Support Buy Rating